Abstract

The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Validation and Improvement Opportunities of the Revised International Staging System for Multiple Myeloma: An Analysis on Mature Data from European Clinical Trials within the Harmony Big Data Platform
Anders Waage ... Hartmut Goldschmidt
Blood | VOL. 134
Anders Waage, et. al.Anders Waage ... Hartmut Goldschmidt
13 Nov 2019
Real World Assessment of Treatment Patterns and Outcomes Among Multiple Myeloma Patients across Different Risk Stratification Criteria in the United States: A Retrospective Cohort Study
Alissa Keegan ... Jazmine Mateus
Blood | VOL. 138
Alissa Keegan, et. al.Alissa Keegan ... Jazmine Mateus
05 Nov 2021
The second revision of the International Staging System (R2-ISS) stratifies progression-free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population.
Peter Mollee ... Andrew Spencer
British journal of haematology | VOL. 200
Peter Mollee, et. al.Peter Mollee ... Andrew Spencer
02 Nov 2022
Evaluation of Revised International Staging System for Transplant-Eligible Multiple Myeloma Patients
Craig B Reeder ... Susan Luft
Blood | VOL. 128
Craig B Reeder, et. al.Craig B Reeder ... Susan Luft
02 Dec 2016
View more papers

More From: HemaSphere

Paper Title
Journal
Date
Author
An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemia.
Zicong Huang ... Hongsheng Zhou
HemaSphere | VOL. 8
Zicong Huang, et. al.Zicong Huang ... Hongsheng Zhou
01 May 2024
Interplay between α-thalassemia and β-hemoglobinopathies: Translating genotype-phenotype relationships into therapies.
Jim Vadolas ... George Grigoriadis
HemaSphere | VOL. 8
Jim Vadolas, et. al.Jim Vadolas ... George Grigoriadis
01 May 2024
Towarda more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS).
Fabio Efficace ... Amer M Zeidan
HemaSphere | VOL. 8
Fabio Efficace, et. al.Fabio Efficace ... Amer M Zeidan
01 May 2024
-
-
HemaSphere | VOL. 8
--
01 May 2024
View more papers